Ovarian cancer

More evidence that beta blockers help stop cancers from spreading

US researchers have taken a step forward in understanding how beta blockers may slow the spread of cancer. US researchers have taken a step forward in understanding how beta blockers may slow the spread of cancer.

30 January 2013

Cervical smear tests 'could also detect ovarian and womb cancer'

DNA from cervical screening samples could also be used to detect ovarian and womb (endometrial) cancers, according to preliminary US research. DNA from cervical screening samples could also be used to detect ovarian and womb (endometrial) cancers, according to preliminary US research.

10 January 2013

• Health & Medicine

High-risk women may need more frequent ovarian cancer screening

Screening women at high risk of ovarian cancer once a year may not be effective enough to spot the disease in its earlier stages, and more frequent screening may be needed for this group of women, according to new research published in the Journal of Clinical Oncology. Screening women at high risk of ovarian cancer once a year may not be effective enough to spot the disease in its earlier stages, and more frequent screening may be needed for this group of women, according to new research published in the Journal of Clinical Oncology.

7 December 2012

Death rates from ovarian cancer have fallen by 20 per cent over last decade

The rates of women dying from ovarian cancer in England have fallen from 11.2 women in every 100,000 (3,820 cases) in 2001 to 8.8 per 100,000 (3,453 cases) in 2010 – a drop of around 20 per cent, according to a new report by the National Cancer Intelligence Network published, today. The rates of women dying from ovarian cancer in England have fallen from 11.2 women in every 100,000 (3,820 cases) in 2001 to 8.8 per 100,000 (3,453 cases) in 2010 – a drop of around 20 per cent, according to a new report by the National Cancer Intelligence Network published, today.

20 November 2012

• Health & Medicine

First figures help set the standard for gynaecological cancer surgery

According to research, one in five women who have major gynaecological cancer surgery will have some sort of complication. According to research, one in five women who have major gynaecological cancer surgery will have some sort of complication.

5 November 2012

• Health & Medicine

Treating late-stage ovarian cancer - why does the UK do so badly?

3 October 2012

• Health & Medicine

Differences in treatment for advanced ovarian cancer could explain why UK survival lags behind other countries

The main reason women are less likely to survive ovarian cancer in the UK than in other comparable countries appears to be due to very low survival in those with more advanced stages of the disease, shows new research published in the journal Gynecologic Oncology. The main reason women are less likely to survive ovarian cancer in the UK than in other comparable countries appears to be due to very low survival in those with more advanced stages of the disease, shows new research published in the journal Gynecologic Oncology.

3 October 2012

• Health & Medicine

Cancer death rates continue to fall

25 September 2012

• Science & Technology
• Health & Medicine

Gene helps predict which women with ovarian cancer will benefit most from chemotherapy

Measuring how active a gene is in women with ovarian cancer could predict who will benefit from platinum-based chemotherapy drugs – a common treatment for the disease. Measuring how active a gene is in women with ovarian cancer could predict who will benefit from platinum-based chemotherapy drugs – a common treatment for the disease.

19 September 2012

• Health & Medicine

Cancer Research UK initiative attracts innovative targeted cancer trials to the UK

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK. A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

31 May 2012

• Science & Technology
• Health & Medicine

Could a blood test reveal cancer’s genetic secrets?

30 May 2012

Blood test gives 'real-time' picture of cancer

A simple and cost-effective blood test could be used to monitor how a patient is responding to treatment and detect genetic faults in their cancer as they happen, according to a Cancer Research UK study. A simple and cost-effective blood test could be used to monitor how a patient is responding to treatment and detect genetic faults in their cancer as they happen, according to a Cancer Research UK study.

30 May 2012